Identification of two novel glial-restricted cell populations in the embryonic telencephalon arising from unique origins
© Strathmann et al; licensee BioMed Central Ltd. 2007
Received: 20 December 2006
Accepted: 17 April 2007
Published: 17 April 2007
Considerably less attention has been given to understanding the cellular components of gliogenesis in the telencephalon when compared to neuronogenesis, despite the necessity of normal glial cell formation for neurological function. Early proposals of exclusive ventral oligodendrocyte precursor cell (OPC) generation have been challenged recently with studies revealing the potential of the dorsal telencephalon to also generate oligodendrocytes. The identification of OPCs generated from multiple regions of the developing telencephalon, together with the need of the embryonic telencephalon to provide precursor cells for oligodendrocytes as well as astrocytes in ventral and dorsal areas, raises questions concerning the identity of the precursor cell populations capable of generating macroglial subtypes during multiple developmental windows and in differing locations.
We have identified progenitor populations in the ventral and dorsal telencephalon restricted to the generation of astrocytes and oligodendrocytes. We further demonstrate that the dorsal glial progenitor cells can be generated de novo from the dorsal telencephalon and we demonstrate their capacity for in vivo production of both myelin-forming oligodendrocytes and astrocytes upon transplantation.
Based on our results we offer a unifying model of telencephalic gliogenesis, with the generation of both oligodendrocytes and astrocytes from spatially separate, but functionally similar, glial restricted populations at different developmental times in the dorsal and ventral CNS.
Within the central nervous system (CNS), the greatest progress in identifying the specific cell populations involved in development has been achieved in the spinal cord. In the rat spinal cord, E10.5 cells have been shown to represent a homogenous population of multipotent neuroepithelial stem cells (NEPs) capable of generating cells of both the neuronal and glial lineage. Differentiated cell types arise from these NEP cells by way of lineage restricted intermediate precursor populations capable of extended proliferation and the generation of neurons or glia. The cells comprising the earliest intermediate precursor population restricted to oligodendrocyte and astrocyte formation, called glial restricted precursor cells (GRPs), can be isolated from the embryonic spinal cord as early as E12. Their ability to generate two antigenically distinct populations of astrocytes and oligodendrocytes has been established both in vitro and in vivo (for review see [1, 2]). GRP cells are identified with the A2B5 antibody and do not express the Polysialylated form of Neural Cell Adhesion Molecule (PSA-NCAM). Freshly isolated GRP cells depend on basic fibroblast growth factor (bFGF) for survival and proliferation but, unlike oligodendrocyte progenitor cells (OPCs ), are not defined by the expression of platelet-derived growth factor receptor-alpha (PDGFR-alpha) or Olig2 . The OPC has been shown in vivo to arise at a later time point than the GRP, and the generation of oligodendrocytes from a GRP population has been demonstrated in vitro to occur through an OPC intermediate stage . Importantly, in both the GRP and OPC populations, the term restricted is used to underscore the greatly diminished, if not non-existent, capacity for neuronal generation when compared to multipotent NEP cells. To date, GRP cells isolated from the spinal cord have failed to generate neurons in numerous paradigms including transplantation into the embryonic spinal cord [5–7]. It has, however, been reported that glial precursor cells isolated from the postnatal optic nerve can be induced to express neuron-like features if cultured for at least one month in serum containing medium , although the significance of this "neuronal potential" remains unclear.
Additional characteristics distinguishing GRP cells from OPCs are the ability of GRP cells to generate two types of astrocytes (that have been designated type-1 and type-2 ) in vitro and to generate both oligodendrocytes and astrocytes in vivo. Both type-1 and type-2 astrocytes are GFAP+, but only type-1 astrocytes co-label with the A2B5 antibody. Type-1 astrocytes are thought to arise from GRP cells through intermediate astrocyte progenitor cells (APC) , while type-2 astrocytes may require prior generation of OPCs as an intermediate step . Unlike OPCs, GRP cells readily generate astrocytes following transplantation into the adult CNS , while primary OPCs thus far only generate oligodendrocytes in such transplantations .
The identification of GRP cells in the spinal cord gave rise to a generalized model of gliogenesis consistent with the majority of experimental data available. This model of gliogenesis involves the progression from a multipotential NEP cell to a lineage restricted multipotent precursor cell population (e.g. GRPs) that in turn give rise to more restricted glial precursor cell types (e.g. OPCs and possibly APCs) and the eventual mature glial cells of the CNS (e.g. oligodendrocytes and astrocytes)[2, 12–14]. While the generation of each cell type in the lineage and the resultant appropriate cellular fate of astrocyte or oligodendrocyte are governed by environmental cues, not all potential cell fates that are observed in vitro may be witnessed in vivo, requiring a careful consideration when interpreting in vitro and in vivo experiments.
In contrast to the spinal cord, the identification of intermediate cellular components of glial cell generation in the telencephalon is largely incomplete. With the OPC the major focus thus far in studies on glial cell generation in the telencephalon, the extent of similarity between intermediate glial precursor cells of the spinal cord and telencephalon is largely unknown. It has been ascertained through genetic and clonal in vitro experiments that a subset of cells from ventral regions of the telencephalon differentiate into PDGFR-alpha+ and/or Olig2+ oligodendrocyte progenitors, migrate away from their ventral origin, and give rise to mature oligodendrocytes throughout the brain [15–20]. It is further assumed that these cells need to express Olig1/2 to be fated towards oligodendrocytes as compound disruption of Olig1 and Olig2 results in a complete loss of oligodendrocytes [21–27]. While these experiments led to the view that the major source for telencephalic oligodendrocytes are ventrally generated OPCs, recent evidence indicates there might be a dorsal origin for a subset, if not majority, of telencephalic oligodendrocytes .
Several populations of PDGFR-alpha+ OPCs in the telencephalon have been identified, each with distinctive spatial and temporal origins [24, 26, 27], but whether the OPC represents the only glial restricted cell in the telencephalon remains unknown. This deficit in our understanding of the glial progenitor populations present in the developing telencephalon also raises the question as to which cells are involved in the generation of astrocytes, a critical cell component of the telencephalon. In addition, while it is well established that cortical NEPs generate neurons, astrocytes, and oligodendrocytes, it is unclear whether or not mature, cortical glial cells are derived from lineage restricted precursor cells or are the product of migrating stem cells in vivo. Although precursor cell populations responsible for glial cell formation in the telencephalon have been described [20, 24, 26, 28], to date no embryonic telencephalic cell has been identified and isolated that possesses the ability to generate both oligodendrocytes and astrocytes in the absence of neuron generation in vitro or in vivo.
With a growing interest in and an increased appreciation for the therapeutic potential of spinal cord derived GRPs  and the role of precursor populations in disease , the aims of this study were to investigate the presence of progenitor populations capable of generating oligodendrocytes and astrocytes but unable to generate neurons, and to determine whether such a progenitor population is derived dorsally and/or ventrally. We began our analysis by isolating cell populations from the dorsal telencephalon based on the antigenic phenotype of restricted precursor cells previously identified in the spinal cord. These telencephalic cells were characterized in mass culture and at the clonal level and were found to generate all macroglial subtypes but were unable to generate neurons. We further determined the dorsal telencephalon is capable of generating this glial restricted population de novo by separating the dorsal telencephalon at a time point where the cell populations present are exclusively of a dorsal origin. In line with the potential dorsal origin of this glial restricted cell population, we identified a ventral glial restricted cell population in parallel. We confirmed the ability of the dorsal cell population to differentiate into myelin producing oligodendrocytes upon transplantation in a myelin deficient background, as well as GFAP+ astrocytes when transplanted into the perinatal forebrain. To our knowledge, these findings represent the first identification of progenitor cells in the embryonic telencephalon that are able to generate both oligodendrocytes and astrocytes but are unable to generate neuronal progeny. Our study also provide for the first time a defined cell population that is generated de novo in the dorsal aspect of the telencephalon and could be the source for both dorsally derived oligodendrocytes and astrocytes. Taken together, our findings provide a general model of gliogenesis by which glial cells originate in a timely and organized manner in the developing telencephalon. This identification and characterization of a telencephalic glial restricted progenitor population is an important step in understanding early telencephalic oligodendrocyte and astrocyte generation and provides a foundation for further investigation into normal and abnormal telencephalic glial cell development.
A2B5+ cells can be detected in the dorsal telencephalon outside of the ventral Olig2 domain
We chose the dorsal telencephalon to pursue our initial identification of a glial restricted progenitor in the telencephalon as this region provides two major advantages over the ventral telencephalon for cell identification: First, OPCs are not detected in the dorsal telencephalon until after E15 (based on PDGFR-alpha expression ), while the ventral telencephalon has been reported to contain OPCs (defined as PDGFR-alpha+ cells) as early as E12.5 . As both GRPs and OPCs are A2B5+ [3, 7], an initial distinction between these two cell types necessitated cell isolation from a specific developmental window in a region such as the E15 dorsal telencephalon, known to possess gliogenic potential but being devoid of the OPC [15, 32]. Second, the dorsal telencephalon consists entirely of dorsal born cells until the time of ventral cell infiltration, at approximately E13.5 in the rat , providing the opportunity to explore the origin of an identified progenitor population.
A2B5 labels a subset of neurons in the dorsal telencephalon
As we could not identify a neuron specific cell surface marker that would allow the separation of the neuronal population (A2B5+/PSA-NCAM-/beta-III tubulin+) from the remaining progenitor population (A2B5+/PSA-NCAM-/beta-III tubulin-), an alternative approach was taken, discussed at length in the Materials and Methods section, using observed differences in adhesion and survival between the neuronal population and the progenitor population.
Defining the A2B5+/PSA-NCAM-/beta-III tubulin- population
Antigenic profile of the A2B5+/PSA-NCAM- population, pre- and post-in vitro growth
Freshly isolated A2B5+/PSA-NCAM- cells
In vitro expanded A2B5+/PSA-NCAM- cells
Beta III Tubulin
In contrast to the absence of neuronal markers and more mature glial lineage markers, putative glial restricted progenitor population were immunoreactive for both Nestin and Sox2, antigens that have been shown to be present in various populations of stem cells [35–38], GRP cells [1, 7, 39], and proliferating astrocytes . While the antigenic profile of the A2B5+/PSA-NCAM-/beta-III tubulin- cell population was not consistent with OPCs, the expression of Nestin and Sox2 did not allow us to distinguish between stem cells and GRP cells. As stem cells differ from GRP cells in their differentiation potential in vitro and in vivo, we conducted a number of experiments that were geared towards the identification of the differentiation potential of the A2B5+/PSA-NCAM-/beta-III tubulin- cell population. To determine a possible lineage restriction of the A2B5+/PSA-NCAM- cell population, it was essential to culture the defined cell population over a minimum of 7 days in a defined condition that allows the expansion of the cells without changing their phenotype.
To establish such a condition, freshly isolated, MACS sorted A2B5+/PSA-NCAM- cells (comprised of a heterogeneous population of A2B5+/PSA-NCAM-/beta-III tubulin+ and of A2B5+/PSA-NCAM-/beta-III tubulin-) were plated in defined medium supplement with bFGF and cultured for 7 days. To determine whether the cells remained unchanged during in vitro growth, the resultant population that was grown for 7 days as describe above and passaged twice were stained with the antibodies listed in Table 1 and compared to freshly isolated cells. The antigenic profile of the cell population that underwent growth and expansion in bFGF in vitro was identical to the antigenic profile of freshly isolated and MACS sorted cells, with the exception of the loss of beta-III tubulin detection (see Table 1). Importantly, the A2B5+/PSA-NCAM-/beta-III tubulin- cell population remained Olig2 negative (even after 3 weeks of in vitro growth in basal media supplemented with 10 ng/ml bFGF (data not shown)). This observation is important as it has been suggested by Gabay et al that bFGF might have a "ventralizing" effect on Olig2 negative dorsal derived spinal cord cells . Our results did not suggest such a role of bFGF in the dorsal-derived telencephalic A2B5+/PSA-NCAM-/beta-III tubulin- cells. In addition, we did not see any spontaneously appearing beta-III tubulin+ cells or any obvious differences in cell morphology, growth rate, or survival during this in vitro growth, further arguing against the "ventralizing" effects in response to bFGF as described by Gabay et al., 2003.
The A2B5+/PSA-NCAM- population generates astrocytes and oligodendrocytes in mass culture but does not generate neurons
In accordance with the generation of oligodendrocytes from spinal cord derived GRP cells, an O4+ intermediate cell type was seen upon exposure to PDGF-AA plus T3/T4 for 4 days (Fig. 4B) Interestingly, BMP-4, shown previously to increase astroglial cell commitment  and implicated in the switch from neuron to astrocyte formation in the telencephalon  was unable to generate GFAP+ cells until 10 days after the onset of BMP exposure (Fig. 4E), but did induce expression of the known GRP derived astrocyte progenitor cell marker, CD44 , after 6 days in vitro (Fig. 4F). Taken together, the results presented thus far confirmed that the A2B5+/PSA-NCAM- dorsal telencephalic cell population is capable of generating oligodendrocytes and astrocytes but not neurons.
The A2B5+/PSA-NCAM- population generates similar numbers of clones containing oligodendrocytes or astrocytes, but no clones containing neurons
While the initial in vitro differentiation experiments indicated the restriction of the A2B5+/PSA-NCAM- population to the glial lineage, a distinction between the presence of a bipotential cell that can generate oligodendrocytes and astrocytes and the presence of a heterogeneous population of APCs and OPCs was necessary. To distinguish between these two possibilities, A2B5+/PSA-NCAM- cells grown in culture for one week were passaged and re-plated at clonal density. Clones were then exposed to bFGF (proliferative), PDGF-AA plus T3T4 (pro-oligodendrocyte), 2% FBS (pro-astrocyte), or NT3 plus RA (pro-neuron) in order to determine the differentiation potential of individual clones. A clone was considered to be capable of generating the specified cell types by the presence of at least one oligodendrocyte per clone, at least one astrocyte per clone, or at least one neuron per clone, in the respective condition.
The splitting of A2B5+/PSA-NCAM- clones reveals the potential to generate oligodendrocytes and astrocytes from a single founder cell
Dorsal glial restricted progenitor cells are generated de novofrom the dorsal telencephalon
The identification of a glial restricted progenitor cell population from the dorsal telencephalon raises the question as to the origin of this population in vivo. In order to determine if the dorsal telencephalon is competent to generate glial restricted progenitor cells de novo, or is a result of ventral cell infiltration, we mechanically separated the E12.5 dorsal telencephalon from the ventral telencephalon and grew the dorsal explant for 2 days in vitro. The physical separation of the dorsal telencephalon from the ventral telencephalon allowed for the simulated development of the dorsal telencephalon in the absence of ventral cell types until a time period comparable to an E15 dorsal telencephalon. As E12.5 is prior to the known entrance of ventral cells into the dorsal telencephalon , any cells present or generated in the two day culture period were decisively of dorsal origin.
Explants were harvested after two days of in vitro growth in Neural Basal Media in the absence of bFGF. This was important as we wanted to minimize the possibility that the culture conditions would lead to a "ventralization" of the explants, although, as described above, we did not observe such an effect in vitro when we cultured dissociated cells in the presence of bFGF.
To further the characterization of the explant derived putative glial restricted progenitor population, A2B5+/PSA-NCAM- cells isolated from 2 day in vitro grown explants were plated at clonal density and the differentiation potential of the clonal progeny was characterized as outlined in Figure 3D. Six clones were selectively passaged and the cells from each clone were divided among four wells of a 24 well plate for exposure to the differentiation conditions. Cells from the split clones were able to generate GalC+ oligodendrocytes in PDGF-AA plus T3/T4 (Fig. 9G), GFAP+ astrocytes in 2% FBS (Fig. 9H), but were unable to generate neurons in NT3 and RA (Fig. 9I). These data confirm the ability of the dorsal telencephalon to give rise to an A2B5+/PSA-NCAM- glial restricted progenitor population independent of cellular migration from ventral regions and indicates a potential dorsal origin for the telencephalic glial restricted progenitor population in vivo.
A ventral glial restricted progenitor cell can be isolated from the E15 rat telencephalon
While our experiments show the existence of a novel glial restricted progenitor cell in the dorsal telencephalon, others have suggested that such cells might also exist in the ventral aspect of the developing telencephalon as early as E12.5 in mouse [24, 31, 44, 45]. As no ventral telencephalic cell from the developing telencephalon has been reported to be able to give rise to astrocytes and oligodendrocytes but not neurons, we expanded our analysis and asked whether a glial restricted precursor cell also exists in the ventral aspect of the early telencephalon.
Due to the multiple origins of OPC generation, we began our analysis of a putative ventral glial restricted progenitor population by dissecting the medial ganglionic eminence (MGE) and the anterior entopeduncular area (AEP) of E15 ventral telencephala. Pdgfr-alpha expression studies indicated OPC presence in these areas , although the cellular origin of the OPCs is not known. The potential problem of isolating a heterogeneous population of glial restricted progenitor cells and OPCs was addressed by growing freshly isolated A2B5+/PSA-NCAM- cells in the presence of 10 ng/ml PDGF. This condition has been previously shown to maintain OPCs but unable to support GRP cell survival . Surviving cells grown in this manner were beta-III tubulin+ and no more than two A2B5+ cells per 1 × 106 total cells were detected (data not shown). Taken together, the absence of a PDGF responsive A2B5+ population and the known inability of OPCs to generate type-1 astrocytes (A2B5-/GFAP+) allowed for the selective determination of a novel ventral glial restricted population.
A2B5+/GFAP+ cells were not detected in 2% FBS or with exposure to ciliary neurotrophic factor (CNTF; Fig. 10C), a condition known to induce A2B5+/GFAP+ Type-2 astrocytes from spinal cord derived GRPs . Type-2 astrocyte generation and oligodendrocyte generation is presently thought to be the differentiation profile of the OPC, while the ability to generate both Type-1 (A2B5-/GFAP+) and Type-2 (A2B5+/GFAP+) astrocytes and GalC+ oligodendrocytes from a restricted glial precursor is characteristic only of the GRP cell. The inability to detect Type-2 astrocyte formation from the telencephalic glial restricted progenitor population is likely attributable to as yet undetermined differences between spinal cord GRPs and telencephalic glial restricted progenitor cells.
For further in vitro characterization, freshly isolated ventral A2B5+/PSA-NCAM- cells were plated at clonal density and selectively passaged and split as outlined in Figure 3D. The cells from a single divided clone generated GalC+ oligodendrocytes in PDGF-AA plus T3/T4 (Fig. 10H), GFAP+ astrocytes in 2% FBS (Fig. 10I) but did not generate neurons in NT3 plus RA (Fig. 10J). These results confirm glial restricted progenitor cells are present in the E15 ventral telencephalon.
In vivoproduction of myelinating oligodendrocytes and astrocytes by telencephalic glial restricted progenitor cells
Our in vitro analyses identified the existence of dorsal and ventral A2B5+/PSA-NCAM- glial restricted progenitor populations in the E15 telencephalon capable of generating oligodendrocytes and/or astrocytes but unable to generate neurons. Our data also indicate that the dorsal telencephalon possesses the potential to generate the A2B5+/PSA-NCAM- glial restricted progenitor population without the presence of ventral cell components. As recent data from several other laboratories have begun to confirm the ability of the dorsal portions of the CNS to provide a subset of myelinating oligodendrocytes [27, 46–49], we wanted to determine whether the dorsal glial restricted progenitor cells we identified in vitro could participate in the myelination of the forebrain.
One hallmark of the spinal cord derived GRP cell that distinguishes this cell from an OPC is its ability to produce astrocytes upon transplantation . In order to determine the in vivo astrocytic potential of the dorsal and ventral telencephalic glial restricted progenitor cells, isolated glial restricted progenitor populations from E15 telencephala of transgenic rat embryos expressing human placental alkaline phosphatase (hPAP; ) were transplanted into the forebrains of P0 Sprague Dawley rat pups, a time point coinciding with peak astrocyte formation  and the beginning of dorsal born oligodendrocyte precursors . At postnatal day 10, pups were sacrificed and sections were analyzed for co-localization of hPAP and GFAP. Double positive cells could be found throughout the transplanted regions of host brains receiving dorsal (Fig. 11D–F) glial restricted progenitors, although regions showing hPAP+ cells not co-localizing with GFAP were also seen. Olig2+/hPAP+ cells could also be visualized in the transplanted regions, indicating the presence of oligodendrocyte precursors (OPCs) and/or oligodendrocytes (Fig. 11G–I). These transplantation studies confirmed the ability of the dorsal glial restricted progenitor population to generate myelinating oligodendrocytes, as well as the ability of the dorsal glial restricted progenitor population to generate astrocytes and cells of the oligodendrocyte lineage upon transplantation.
The identification of these newly characterized tGRP cells allows a refinement and a possible unification of the current view of oligodendrocyte generation. The original model for oligodendrocyte generation in the telencephalon consisted of ventral OPC generation with subsequent dispersal throughout the CNS [21, 46, 55–57]. More recent evidence both corroborates this original idea and necessitates its modification to include multiple sites of oligodendrocyte generation, implicating regions of both the ventral and dorsal CNS [22, 23, 48, 58]. In addition to the regional aspects of the origins of OPC generation, there is also a temporal facet to the generation of OPCs. Three waves of oligodendrocyte precursor formation have been described: OPCs are thought to first originate from a region consisting of the Nkx2.1 expressing anterior entopeduncular area and medial ganglionic eminence . A second wave of OPC generation is thought to originate from the Gsh2 expressing domain of the lateral and/or caudal ganglionic eminence, and the third wave is believed to initiate from the dorsal Emx1 expressing domain .
The aspects of regional distribution of OPCs together with the timing of oligodendrocyte generation in vivo led to a relatively new model that argues for competing waves of telencephalic oligodendrocyte formation, with a "turf war" between the differing OPC populations resulting in a loss of a ventral population and the final oligodendrocyte population being derived from the remaining cell pools . This model is based on observations using separate Cre-lox transgenic animals, with Cre expression driven by a specifically chosen transcription factor unique to the individual OPC populations, crossed to a Rosa26R-GFP transgenic reporter line. Yue et al., 2006 further substantiated the role of dorsally derived OPCs using a cortical specific Olig2 ablation strategy. In spatially restricted ablated animals, the loss of any dorsally derived OPCs created an insurmountable myelin deficit, even with ventral OPC infiltration. These data, however, are in opposition to a recent publication in a separate study. Nakahira et al. (2006) used a Cre-lox system to drive EGFP expression in a non-cell-specific manner, and attributed at least a subset of dorsal oligodendrocytes to a migrating ventral OPC population .
We believe that one of the major obstacles in unifying these observations is a lack of knowledge regarding the cells from which OPCs are generated. In all of the studies mentioned, the cell types targeted are the direct precursors of the myelin forming oligodendrocytes, the OPCs, with little to no attention given to understanding intermediate cell types involved in the generation of the OPCs. In addition, none of the models address a possible source of astrocytes, the major glial component of the CNS. Our studies now provide for the first time the characterization of a cell population that is generated before or in addition to OPCs and could be the possible cell source for dorsal and/or ventral OPC generation, independent of ventral to dorsal cell migration.
Importantly, the identification of tGRPs also offers for the first time a defined potential source for astrocytes. It has been shown in the spinal cord that astrocytes occur in both dorsal and ventral regions , and a subset of astrocytes and oligodendrocytes is shown to arise from cells of ventral origin migrating to and residing in the dorsolateral subventricular zone [24, 28]. Astrocytic populations have also been identified in other regions of the developing telencephalon [28, 32, 60–62], but the source of these cells has remained elusive. tGRPs that arise both ventrally and dorsally could account for the generation of at least a subset of astrocytes in the developing telencephalon.
The identification of GRP cells in both spinal cord and telencephalon begs the question of whether the process of gliogenesis involves similar cellular components independent of where in the CNS mature glial cells are produced. The models that are discussed for gliogenesis are to date specific for spinal cord versus telencephalon and include (i) the motorneuron-oligodendrocyte precursor model (MNOP) for spinal cord, (ii) a possible neuron-oligo model specific to the telencephalon [24, 26], (iii) a sequential model  for spinal cord gliogenesis and (iv) the glial restricted progenitor/neuron restricted progenitor (GRP/NRP) model that was confined to the spinal cord due to the lack of comparable cell types being identified in the telencephalon. The GRP/NRP model is currently the model most supported by in vitro as well as in vivo studies. Spinal cord GRP cells, shown to be generated from more primitive NSC cells , are likely to represent the source for both OPCs and astrocytes in the spinal cord. With the identification of the tGRP populations from regions where OPCs and astrocytes have been described to appear, it is plausible that a similar paradigm exists in the embryonic telencephalon.
In the current study, we identified two A2B5+/PSA-NCAM- cell populations: one isolated from the E15 dorsal telencephalon and the other isolated from the E15 ventral telencephalon. An elaborated analysis of the antigenic profile of these cells that included numerous, currently used antigenic markers was useful but remains non-conclusive. For example, the antigenic profile of the A2B5+/PSA-NCAM- (see Table 1) would be consistent with the cells representing either GRP cells or stem cells. The overlap of antigenic markers of GRP cells with neural stem cells, together with the now emerging possibility of multiple origins of OPCs, has made it difficult to distinguish cells from each other and to assign identities to specific cell pools. It seems clear that the designation of cells as GRP, OPC or NSC requires a more detailed and stringent analysis. One of the most reliable tools that distinguishes stem cells from lineage restricted precursor cell pools is the analysis of the cell type-specific differentiation potential (for review, see Noble et al 2006). While it can be expected that NSC will be able to generate oligodendrocytes, astrocytes and neurons, lineage restricted cells would not display the full array of cell types upon differentiation.
The mass culture analyses, clonal analyses, clone splitting analyses, and in vivo transplantation experiments of the A2B5+/PSA-NCAM-/beta-III tubulin- telencephalic cell population demonstrated their ability to generate cells of the glial lineage but an inability to differentiate into neurons. This differentiation profile strongly resembles that of the previously described GRP population of the E13.5 spinal cord . In addition to the similar differentiation profile, the telencephalic glial restricted progenitor populations are, like the spinal cord GRP population, responsive to bFGF as a mitogen and survival factor  and can also be isolated from both dorsal and ventral aspects of the respective tissues . Our data also establishes the capability of the dorsal telencephalon to generate a telencephalic glial restricted progenitor population in the absence of ventral cell tissue. These observations suggest that the dorsally derived GRP cell population might actually represent the source for at least a subset of dorsally derived mature glial cells.
There were, however, readily detectable differences between the telencephalic cells and the previously studied spinal cord cells, including the astrocyte generation upon exposure to BMP-4, as well as a lack of type-2 astrocyte generation in response to CNTF . The last characteristic, in particular, makes a distinction between this novel progenitor cell population and the extensively studied OPCs isolated from postnatal rat brains. In order to distinguish this telencephalic glial restricted population from not only the PDGFR-alpha+ OPC population, but also the spinal cord GRP population, we suggest the designation of the telencephalic cell populations as telencephalic glial restricted progenitors (tGRP).
Future topics of interest include the characterization of the time point of generation of the tGRP populations in the telencephalon, the contribution of each population to the mature glial cell component in their respective locations, and the potential presence of a natural or inducible fate switch to occur allowing for the modulation of glial cell type generation. As the tGRP populations are present during the peak of neuron formation, a contribution by this population to the cytoarchitectonics of the early telencephalon may also be of considerable interest.
A2B5+/PSA-NCAM- cells were isolated from embryonic day 15 (E15) Sprague Dawley rat telencephala using A2B5 and an antibody recognizing the polysialylated form of neural cell adhesion molecule (PSA-NCAM) [7, 39, 64] in combination with magnetic separation using Miltenyi MACS Cell Separation Columns (Miltenyi Biotech). For explant studies, the dorsal telencephala was removed from E13 Sprague Dawley rats and placed on Millicell culture plate inserts for two days of in vitro growth in Neural Basal Media (Gibco) with the addition of 2 mM Glutamax (Gibco) and B27 Supplement minus AO (Gibco), before being immunopurified as above. Cells were grown on fibronectin/laminin-coated glass coverslips at 1000 cells per well of a 24 well plate for mass culture experiments or at 500 cells per T25 flask and/or 40 cells per well of a 24 well plate for clonal analysis. For propagation, cultures were grown in DMEM-F12 supplemented with additives described by Bottenstein and Sato  and basic fibroblast growth factor (bFGF: 10 ng/ml). At the specified time, cells were stained with A2B5 antibody  to detect precursor cells, anti-galactocerebroside (GalC)  to identify oligodendrocytes, anti-GFAP antiserum to identify astrocytes [68, 69] and anti-beta-III tubulin  to detect neurons, followed by the appropriate fluorochrome conjugated secondary antibodies (Molecular Probes).
In vitroculture of A2B5+/PSA-NCAM- cells and the loss of beta-III tubulin+ cells
Over the course of a one week in vitro culture period, the cells were passaged twice, which resulted in a loss of the A2B5+/PSA-NCAM-/beta-III tubulin+ neuronal population (see Figure 3C). The loss of this neuronal population is attributable to two factors: (i) our medium condition was not permissive for the survival of the neuronal A2B5+/PSA-NCAM-/beta-III tubulin+ cells, but was sufficient to allow survival and proliferation of the non-neuronal A2B5+/PSA-NCAM-/beta-III tubulin- population, and (ii) a difference in substrate binding between the neuronal and putative glial progenitor populations. To attribute the loss of the neuronal population to the growth conditions used for expansion of the putative GRPs, we also cultured the freshly isolated, heterogeneous A2B5+/PSA-NCAM- populations in the presence of PDGF-AA, a factor that has been shown to support neuronal survival . We found that this condition was supportive of the survival of A2B5+/PSA-NCAM-/beta-III tubulin+ cells, with a detection of non-neuronal A2B5+/PSA-NCAM-/beta-III tubulin- cells at no more than two cells per 1 × 106 total cells (0.0002%; data not shown). In regards to the observed difference in substrate binding, the neuronal A2B5+/PSA-NCAM-/beta-III tubulin+ cells were less adherent to fibronectin/laminin coated surfaces when compared to the A2B5+/PSA-NCAM-/beta-III tubulin- cells and contributed to the loss of the neuronal population during passaging. As a direct application of the above findings, growth of the freshly isolated A2B5+/PSA-NCAM- population (containing both putative glial restricted progenitors and neurons) in 10 ng/ml bFGF on fibronectin/laminin resulted in the purification of the non-neuronal A2B5+/PSA-NCAM-/beta-III tubulin- population.
Mass culture and clonal analysis of telencephalon populations
Mass culture and clonal differentiation analyses were used to confirm the differentiation potential of cell populations and individual precursor cells, respectively, as used previously in GRP cell characterization from the spinal cord [7, 10, 64], as well as in characterization of OPCs [71, 72]. Cells were isolated as described above and grown in bFGF for 1 week prior to replating for mass culture or clonal density. Cells were propagated in bFGF for 2 days prior to exposure to one of the following conditions: 10 ng/ml bFGF (control: proliferative), 10 ng/ml Bone Morphogenic Protein 4 (BMP-4: astrocyte induction), 2% Fetal Bovine Serum (FBS: astrocyte induction), 1 ng/ml Platelet Derived Growth Factor (PDGF-AA) plus a mixture of 49 nM Triiodothyronine and 45 nM Thyroxine (PDGF-AA + T3/T4: oligodendrocyte induction), or 10 ng/ml Neurotrophin-3 plus 100 nM Retinoic Acid (NT3 + RA: neuron induction).
Embryos from various developmental ages were immersed in cold isopentane (Sigma) and stored at -80°C until sectioned. 10 μm sections were cut using a Shandon Cryotome Cryostat and collected on Superfrost Plus slides (VWR). Slides were air dried at room temperature overnight and processed for primary antibody staining or stored at -80°C. Sections were fixed by immersion in 4% paraformaldehyde for 10 minutes at room temperature followed by a 2 minute acetone exposure at -20°C. All washing steps were carried out in Tris buffered saline. Blocking buffer consisted of 0.5 M TBS with 5% Goat Serum and 4% Bovine Serum Albumin.
Fluorescence activated cell sorting analysis
Freshly dissociated cells were stained with primary antibodies that included anti-PSA-NCAM with a secondary anti-IgM-PE conjugate, and A2B5 conjugated directly to fluorescein. FACS staining was conducted at 4°C in the following sequence: Primary PSA-NCAM, secondary IgM-PE, primary A2B5-FITC. Flow cytometry was performed on a Becton Dickinson FACSCalibur and analysis was done using CELLQuest software.
Immunostaining of cells and sections
All primary antibody stains were done at 4°C overnight, followed by a 30 minute stain with the appropriate secondary. A2B5, PSA-NCAM, O4, Ran2 and GalC hybridoma supernatants (American Type Culture Collection) were used at 1:10 dilutions. 3CB2 and RC2 hybridoma supernatants (Developmental Studies Hybridoma Bank) were used at 1:50. GFAP rabbit polyclonal antibody (Dako) and beta-III tubulin (BioGenex) were used at 1:400. Sox2 (Chemicon), Sox10 (Sigma), Nestin (Rat 401; Chemicon), NG2 (Chemicon), S100 (Chemicon) and PDGFR alpha (Santa Cruz Biotechnology) antibodies were used at 1:500. CD44 antibody (Accurate) and human Placental Alkaline Phosphatase antibody (Sigma) were used at 1:1000. An Olig2 specific polyclonal antibody [25, 73, 74] (a generous gift from D. Rowitch) was used at 1:40,000. All secondary antibodies were purchased from Molecular Probes and included goat anti-mouse IgG3, IgM, IgG2a, and goat anti-rabbit Ig (heavy and light chain) conjugated to Alexa-488, Alexa-350, Alexa-546 or Alexa-568.
Clonal splitting experiments
Immunopurified cells were plated at clonal density and grown in 10 ng/ml bFGF until clones were detected containing approximately 200 cells. These clones were then selectively passaged and split into four separate wells containing one of the following: 10 ng/ml bFGF, 2% FBS, 1 ng/ml PDGF-AA plus a mix of 45 nM T3 and 49 nM T4, or 10 ng/ml NT-3 plus 100 nM RA. Media was changed every other day for six days and cells were processed for immunostaining as indicated above.
Postnatal day 18 homozygous shiverer mice were anesthetized with 25 μl of a 100 μg/μl solution of ketamine prior to transplantation. A 0.34 mm needle was used to inject 1.5 μl of PBS containing 1 × 105 A2B5+/PSA-NCAM- cells at four injection sites lateral to the cortical hem of the left hemisphere. The needle was inserted to a depth of 3 mm and remained in the injection site for 1 minute prior to removal. Shiverer mice undergoing the transplantation procedure were sacrificed three weeks post-transplantation for analysis. Postnatal day 0 Sprague Dawley rat pups were anesthetized by hypothermia for hPAP expressing, telencephalic cell transplantation. 8–9 sites were injected with 27.6 nl per injection site at a depth of 1 mm into the left hemisphere. Rat pups receiving cell transplantations were sacrificed at postnatal day 10 and processed for immunofluorescence as described above.
Animals that underwent cell transplantation were perfused with a mixture of paraformaldehyde and gluteraldehyde warmed to 38°C. Brains were removed and sectioned into 1 mm coronal sections using a Braintree Scientific 1 mm mouse acrylic matrix. Each section was fixed overnight in paraformaldehyde/gluteraldehyde mix, rinsed with phosphate buffer, pH 7.4, and post-fixed in phosphate buffered 1.0% osmium tetroxide for 1.5 hours. The 1 mm sections were dehydrated in a graded series of ethanol (ETOH) to 100%, transitioned into 100% propylene oxide and infiltrated in Epon/Araldite (Electron Microscopy Sciences, Fort Washington, PA) epoxy resin overnight. Sections were embedded into molds with fresh resin and polymerized for two days at 70°C. Semi-thin two micron sections were cut and stained with 0.5% toluidine blue in 2% sodium borate and examined under a light microscope to determine the area to be thin sectioned. Thin sections were cut with a diamond knife and placed on 200 mesh copper grids and stained with uranyl acetate and lead citrate. The grids were examined with a Hitachi 7100 Transmission Electron Microscope and digital images were captured using a MegaView III digital camera (AnalySIS, Lakewood, CO).
We thank all members of our laboratory for enthusiastic and helpful discussions. We thank Mark Noble, Christoph Pröschel and Daniel C. Tanner for critical reading of the manuscript. We thank Karen L. Bentley of the University of Rochester'sElectron Microscope Research Corefor her expertise in generating the EM images and data. The work was supported by R01 NS0428200251 (MMP) and NINDS Training Grant 1T32NS051152-01 in Neuroinflammation and Glial Cell Biology (FS).
- Mayer-Proschel M: Cell differentiation in the embryonic mammalian spinal cord. J Neural Transm Suppl. 1999, 55: 1-8.PubMedGoogle Scholar
- Noble M, Proschel C, Mayer-Proschel M: Getting a GR(i)P on oligodendrocyte development. Dev Biol. 2004, 265 (1): 33-52. 10.1016/j.ydbio.2003.06.002.View ArticlePubMedGoogle Scholar
- Raff MC, Miller RH, Noble M: A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature. 1983, 303 (5916): 390-396. 10.1038/303390a0.View ArticlePubMedGoogle Scholar
- Gregori N, Proschel C, Noble M, Mayer-Proschel M: The tripotential glial-restricted precursor (GRP) cell and glial development in the spinal cord: generation of bipotential oligodendrocyte-type-2 astrocyte progenitor cells and dorsal-ventral differences in GRP cell function. J Neurosci. 2002, 22 (1): 248-256.PubMedGoogle Scholar
- Han SS, Liu Y, Tyler-Polsz C, Rao MS, Fischer I: Transplantation of glial-restricted precursor cells into the adult spinal cord: survival, glial-specific differentiation, and preferential migration in white matter. Glia. 2004, 45 (1): 1-16. 10.1002/glia.10282.View ArticlePubMedGoogle Scholar
- Hill CE, Proschel C, Noble M, Mayer-Proschel M, Gensel JC, Beattie MS, Bresnahan JC: Acute transplantation of glial-restricted precursor cells into spinal cord contusion injuries: survival, differentiation, and effects on lesion environment and axonal regeneration. Experimental Neurology. 2004, 190 (2): 289-310. 10.1016/j.expneurol.2004.05.043.View ArticlePubMedGoogle Scholar
- Rao MS, Noble M, Mayer-Proschel M: A tripotential glial precursor cell is present in the developing spinal cord. Proc Natl Acad Sci U S A. 1998, 95 (7): 3996-4001. 10.1073/pnas.95.7.3996.PubMed CentralView ArticlePubMedGoogle Scholar
- Kondo T, Raff M: Oligodendrocyte precursor cells reprogrammed to become multipotential CNS stem cells. Science. 2000, 289 (5485): 1754-1757. 10.1126/science.289.5485.1754.View ArticlePubMedGoogle Scholar
- Liu Y, Han SSW, Wu Y, Tuohy TMF, Xue H, Cai J, Back SA, Sherman LS, Fischer I, Rao MS: CD44 expression identifies astrocyte-restricted precursor cells. Developmental Biology. 2004, 276 (1): 31-46. 10.1016/j.ydbio.2004.08.018.View ArticlePubMedGoogle Scholar
- Herrera J, Yang H, Zhang SC, Proschel C, Tresco P, Duncan ID, Luskin M, Mayer-Proschel M: Embryonic-derived glial-restricted precursor cells (GRP cells) can differentiate into astrocytes and oligodendrocytes in vivo. Exp Neurol. 2001, 171 (1): 11-21. 10.1006/exnr.2001.7729.View ArticlePubMedGoogle Scholar
- Espinosa de los Monteros A, Zhang M, De Vellis J: O2A progenitor cells transplanted into the neonatal rat brain develop into oligodendrocytes but not astrocytes. Proc Natl Acad Sci U S A. 1993, 90 (1): 50-54. 10.1073/pnas.90.1.50.PubMed CentralView ArticlePubMedGoogle Scholar
- Liu Y, Wu Y, Lee JC, Xue H, Pevny LH, Kaprielian Z, Rao MS: Oligodendrocyte and astrocyte development in rodents: an in situ and immunohistological analysis during embryonic development. Glia. 2002, 40 (1): 25-43. 10.1002/glia.10111.View ArticlePubMedGoogle Scholar
- Liu Y, Rao MS: Glial progenitors in the CNS and possible lineage relationships among them. Biol Cell. 2004, 96 (4): 279-290. 10.1016/j.biolcel.2004.02.001.View ArticlePubMedGoogle Scholar
- Noble M, Arhin A, Gass D, Mayer-Proschel M: The cortical ancestry of oligodendrocytes: common principles and novel features. Dev Neurosci. 2003, 25 (2-4): 217-233. 10.1159/000072270.View ArticlePubMedGoogle Scholar
- LeVine SM, Goldman JE: Embryonic divergence of oligodendrocyte and astrocyte lineages in developing rat cerebrum. J Neurosci. 1988, 8 (11): 3992-4006.PubMedGoogle Scholar
- Levison SW, Goldman JE: Both oligodendrocytes and astrocytes develop from progenitors in the subventricular zone of postnatal rat forebrain. Neuron. 1993, 10 (2): 201-212. 10.1016/0896-6273(93)90311-E.View ArticlePubMedGoogle Scholar
- Brittis PA, Meiri K, Dent E, Silver J: The earliest patterns of neuronal differentiation and migration in the mammalian central nervous system. Exp Neurol. 1995, 134 (1): 1-12. 10.1006/exnr.1995.1031.View ArticlePubMedGoogle Scholar
- Gotz M: Getting there and being there in the cerebral cortex. Experientia. 1995, 51 (4): 301-316. 10.1007/BF01928886.View ArticlePubMedGoogle Scholar
- Jimenez D, Lopez-Mascaraque LM, Valverde F, De Carlos JA: Tangential migration in neocortical development. Dev Biol. 2002, 244 (1): 155-169. 10.1006/dbio.2002.0586.View ArticlePubMedGoogle Scholar
- Anderson SA, Marin O, Horn C, Jennings K, Rubenstein JL: Distinct cortical migrations from the medial and lateral ganglionic eminences. Development. 2001, 128 (3): 353-363.PubMedGoogle Scholar
- Pringle NP, Richardson WD: A singularity of PDGF alpha-receptor expression in the dorsoventral axis of the neural tube may define the origin of the oligodendrocyte lineage. Development. 1993, 117 (2): 525-533.PubMedGoogle Scholar
- Hardy RJ, Friedrich VL: Oligodendrocyte progenitors are generated throughout the embryonic mouse brain, but differentiate in restricted foci. Development. 1996, 122 (7): 2059-2069.PubMedGoogle Scholar
- Spassky N, Goujet-Zalc C, Parmantier E, Olivier C, Martinez S, Ivanova A, Ikenaka K, Macklin W, Cerruti I, Zalc B, Thomas JL: Multiple restricted origin of oligodendrocytes. J Neurosci. 1998, 18 (20): 8331-8343.PubMedGoogle Scholar
- He W, Ingraham C, Rising L, Goderie S, Temple S: Multipotent Stem Cells from the Mouse Basal Forebrain Contribute GABAergic Neurons and Oligodendrocytes to the Cerebral Cortex during Embryogenesis. J Neurosci. 2001, 21 (22): 8854-8862.PubMedGoogle Scholar
- Nery S, Wichterle H, Fishell G: Sonic hedgehog contributes to oligodendrocyte specification in the mammalian forebrain. Development. 2001, 128 (4): 527-540.PubMedGoogle Scholar
- Yung SY, Gokhan S, Jurcsak J, Molero AE, Abrajano JJ, Mehler MF: Differential modulation of BMP signaling promotes the elaboration of cerebral cortical GABAergic neurons or oligodendrocytes from a common sonic hedgehog-responsive ventral forebrain progenitor species. Proc Natl Acad Sci U S A. 2002, 99 (25): 16273-16278. 10.1073/pnas.232586699.PubMed CentralView ArticlePubMedGoogle Scholar
- Kessaris N, Fogarty M, Iannarelli P, Grist M, Wegner M, Richardson WD: Competing waves of oligodendrocytes in the forebrain and postnatal elimination of an embryonic lineage. Nat Neurosci. 2006, 9 (2): 173-179. 10.1038/nn1620.View ArticlePubMedGoogle Scholar
- Marshall CA, Goldman JE: Subpallial dlx2-expressing cells give rise to astrocytes and oligodendrocytes in the cerebral cortex and white matter. J Neurosci. 2002, 22 (22): 9821-9830.PubMedGoogle Scholar
- Davies J, Huang C, Proschel C, Noble M, Mayer-Proschel M, Davies S: Astrocytes derived from glial-restricted precursors promote spinal cord repair. Journal of Biology. 2006, 5 (3): 7-10.1186/jbiol35.PubMed CentralView ArticlePubMedGoogle Scholar
- Mayer-Proschel M, Morath D, Noble M: Are hypothyroidism and iron deficiency precursor cell diseases?. Dev Neurosci. 2001, 23 (4-5): 277-286. 10.1159/000048711.View ArticlePubMedGoogle Scholar
- Tekki-Kessaris N, Woodruff R, Hall AC, Gaffield W, Kimura S, Stiles CD, Rowitch DH, Richardson WD: Hedgehog-dependent oligodendrocyte lineage specification in the telencephalon. Development. 2001, 128 (13): 2545-2554.PubMedGoogle Scholar
- Parnavelas JG: Glial cell lineages in the rat cerebral cortex. Exp Neurol. 1999, 156 (2): 418-429. 10.1006/exnr.1999.7044.View ArticlePubMedGoogle Scholar
- Anderson SA, Eisenstat DD, Shi L, Rubenstein JL: Interneuron migration from basal forebrain to neocortex: dependence on Dlx genes. Science. 1997, 278 (5337): 474-476. 10.1126/science.278.5337.474.View ArticlePubMedGoogle Scholar
- Dahlstrand J, Lardelli M, Lendahl U: Nestin mRNA expression correlates with the central nervous system progenitor cell state in many, but not all, regions of developing central nervous system. Developmental Brain Research. 1995, 84 (1): 109-129. 10.1016/0165-3806(94)00162-S.View ArticlePubMedGoogle Scholar
- Lendahl U, Zimmerman LB, McKay RDG: CNS stem cells express a new class of intermediate filament protein. Cell. 1990, 60 (4): 585-595. 10.1016/0092-8674(90)90662-X.View ArticlePubMedGoogle Scholar
- Bani-Yaghoub M, Tremblay RG, Lei JX, Zhang D, Zurakowski B, Sandhu JK, Smith B, Ribecco-Lutkiewicz M, Kennedy J, Walker PR, Sikorska M: Role of Sox2 in the development of the mouse neocortex. Developmental Biology. In Press, Corrected Proof:
- Miyagi S, Nishimoto M, Saito T, Ninomiya M, Sawamoto K, Okano H, Muramatsu M, Oguro H, Iwama A, Okuda A: The Sox2 Regulatory Region 2 Functions as a Neural Stem Cell-specific Enhancer in the Telencephalon. J Biol Chem. 2006, 281 (19): 13374-13381. 10.1074/jbc.M512669200.View ArticlePubMedGoogle Scholar
- Rao MS, Mayer-Proschel M: Glial-restricted precursors are derived from multipotent neuroepithelial stem cells. Dev Biol. 1997, 188 (1): 48-63. 10.1006/dbio.1997.8597.View ArticlePubMedGoogle Scholar
- Gabay L, Lowell S, Rubin LL, Anderson DJ: Deregulation of dorsoventral patterning by FGF confers trilineage differentiation capacity on CNS stem cells in vitro. Neuron. 2003, 40 (3): 485-499. 10.1016/S0896-6273(03)00637-8.View ArticlePubMedGoogle Scholar
- Mujtaba T, Mayer-Proschel M, Rao MS: A common neural progenitor for the CNS and PNS. Dev Biol. 1998, 200 (1): 1-15. 10.1006/dbio.1998.8913.View ArticlePubMedGoogle Scholar
- Mabie PC, Mehler MF, Marmur R, Papavasiliou A, Song Q, Kessler JA: Bone morphogenetic proteins induce astroglial differentiation of oligodendroglial-astroglial progenitor cells. J Neurosci. 1997, 17 (11): 4112-4120.PubMedGoogle Scholar
- Kasai M, Satoh K, Akiyama T: Wnt signaling regulates the sequential onset of neurogenesis and gliogenesis via induction of BMPs. Genes to Cells. 2005, 10 (8): 777-783. 10.1111/j.1365-2443.2005.00876.x.View ArticlePubMedGoogle Scholar
- Park HC, Appel B: Delta-Notch signaling regulates oligodendrocyte specification. Development. 2003, 130 (16): 3747-3755. 10.1242/dev.00576.View ArticlePubMedGoogle Scholar
- Qi Y, Stapp D, Qiu M: Origin and molecular specification of oligodendrocytes in the telencephalon. Trends Neurosci. 2002, 25 (5): 223-225. 10.1016/S0166-2236(02)02145-8.View ArticlePubMedGoogle Scholar
- Cameron-Curry P, Le Douarin NM: Oligodendrocyte precursors originate from both the dorsal and the ventral parts of the spinal cord. Neuron. 1995, 15 (6): 1299-1310. 10.1016/0896-6273(95)90009-8.View ArticlePubMedGoogle Scholar
- Fogarty M, Richardson WD, Kessaris N: A subset of oligodendrocytes generated from radial glia in the dorsal spinal cord. Development. 2005, 132 (8): 1951-1959. 10.1242/dev.01777.View ArticlePubMedGoogle Scholar
- Vallstedt A, Klos JM, Ericson J: Multiple Dorsoventral Origins of Oligodendrocyte Generation in the Spinal Cord and Hindbrain. Neuron. 2005, 45 (1): 55-67. 10.1016/j.neuron.2004.12.026.View ArticlePubMedGoogle Scholar
- Nakahira E, Kagawa T, Shimizu T, Goulding MD, Ikenaka K: Direct evidence that ventral forebrain cells migrate to the cortex and contribute to the generation of cortical myelinating oligodendrocytes. Developmental Biology. 2006, In Press, Corrected Proof:Google Scholar
- Bird TD, Farrell DF, Sumi SM: Brain lipid composition of the shiverer mouse: (genetic defect in myelin development). J Neurochem. 1978, 31 (1): 387-391. 10.1111/j.1471-4159.1978.tb12479.x.View ArticlePubMedGoogle Scholar
- Chernoff GF: Shiverer: an autosomal recessive mutant mouse with myelin deficiency. J Hered. 1981, 72 (2): 128-PubMedGoogle Scholar
- Molineaux SM, Engh H, Ferra FD, Hudson L, Lazzarini RA: Recombination within the Myelin Basic Protein Gene Created the Dysmyelinating Shiverer Mouse Mutation. PNAS. 1986, 83 (19): 7542-7546. 10.1073/pnas.83.19.7542.PubMed CentralView ArticlePubMedGoogle Scholar
- Kisseberth WC, Brettingen NT, Lohse JK, Sandgren EP: Ubiquitous expression of marker transgenes in mice and rats. Dev Biol. 1999, 214 (1): 128-138. 10.1006/dbio.1999.9417.View ArticlePubMedGoogle Scholar
- Qian X, Shen Q, Goderie SK, He W, Capela A, Davis AA, Temple S: Timing of CNS cell generation: a programmed sequence of neuron and glial cell production from isolated murine cortical stem cells. Neuron. 2000, 28 (1): 69-80. 10.1016/S0896-6273(00)00086-6.View ArticlePubMedGoogle Scholar
- Warf BC, Fok-Seang J, Miller RH: Evidence for the ventral origin of oligodendrocyte precursors in the rat spinal cord. J Neurosci. 1991, 11 (8): 2477-2488.PubMedGoogle Scholar
- Noll E, Miller RH: Oligodendrocyte precursors originate at the ventral ventricular zone dorsal to the ventral midline region in the embryonic rat spinal cord. Development. 1993, 118 (2): 563-573.PubMedGoogle Scholar
- Ono K, Bansal R, Payne J, Rutishauser U, Miller RH: Early development and dispersal of oligodendrocyte precursors in the embryonic chick spinal cord. Development. 1995, 121 (6): 1743-1754.PubMedGoogle Scholar
- Anna I, Eiko N, Tetsushi K, Akio O, Tamaki W, Hirohide T, Nathalie S, Joel L, Bernard Z, Kazuhiro I: Evidence for a second wave of oligodendrogenesis in the postnatal cerebral cortex of the mouse. Journal of Neuroscience Research. 2003, 73 (5): 581-592. 10.1002/jnr.10717.View ArticleGoogle Scholar
- Pringle NP, Guthrie S, Lumsden A, Richardson WD: Dorsal spinal cord neuroepithelium generates astrocytes but not oligodendrocytes. Neuron. 1998, 20 (5): 883-893. 10.1016/S0896-6273(00)80470-5.View ArticlePubMedGoogle Scholar
- Ross SE, Greenberg ME, Stiles CD: Basic helix-loop-helix factors in cortical development. Neuron. 2003, 39 (1): 13-25. 10.1016/S0896-6273(03)00365-9.View ArticlePubMedGoogle Scholar
- Gomes WA, Mehler MF, Kessler JA: Transgenic overexpression of BMP4 increases astroglial and decreases oligodendroglial lineage commitment. Dev Biol. 2003, 255 (1): 164-177. 10.1016/S0012-1606(02)00037-4.View ArticlePubMedGoogle Scholar
- Sauvageot CM, Stiles CD: Molecular mechanisms controlling cortical gliogenesis. Curr Opin Neurobiol. 2002, 12 (3): 244-249. 10.1016/S0959-4388(02)00322-7.View ArticlePubMedGoogle Scholar
- Wu S, Wu Y, Capecchi MR: Motoneurons and oligodendrocytes are sequentially generated from neural stem cells but do not appear to share common lineage-restricted progenitors in vivo. Development. 2006, dev.02236-Google Scholar
- Mayer-Proschel M, Kalyani AJ, Mujtaba T, Rao MS: Isolation of lineage-restricted neuronal precursors from multipotent neuroepithelial stem cells. Neuron. 1997, 19 (4): 773-785. 10.1016/S0896-6273(00)80960-5.View ArticlePubMedGoogle Scholar
- Bottenstein JE, Sato GH: Growth of a Rat Neuroblastoma Cell Line in Serum-Free Supplemented Medium. PNAS. 1979, 76 (1): 514-517. 10.1073/pnas.76.1.514.PubMed CentralView ArticlePubMedGoogle Scholar
- Schnitzer J, Schachner M: Cell type specificity of a neural cell surface antigen recognized by the monoclonal antibody A2B5. Cell Tissue Res. 1982, 224 (3): 625-636. 10.1007/BF00213757.View ArticlePubMedGoogle Scholar
- Bansal R, Warrington AE, Gard AL, Ranscht B, Pfeiffer SE: Multiple and novel specificities of monoclonal antibodies O1, O4, and R-mAb used in the analysis of oligodendrocyte development. J Neurosci Res. 1989, 24 (4): 548-557. 10.1002/jnr.490240413.View ArticlePubMedGoogle Scholar
- Bignami A, Dahl D: Differentiation of astrocytes in the cerebellar cortex and the pyramidal tracts of the newborn rat. An immunofluorescence study with antibodies to a protein specific to astrocytes. Brain Res. 1973, 49 (2): 393-402. 10.1016/0006-8993(73)90430-7.View ArticlePubMedGoogle Scholar
- Norton WT, Farooq M: Differentiation of glial precursor cells from developing rat brain in vitro. Brain Res Dev Brain Res. 1993, 72 (2): 193-202. 10.1016/0165-3806(93)90184-C.View ArticlePubMedGoogle Scholar
- Caccamo D, Katsetos CD, Herman MM, Frankfurter A, Collins VP, Rubinstein LJ: Immunohistochemistry of a spontaneous murine ovarian teratoma with neuroepithelial differentiation. Neuron-associated beta-tubulin as a marker for primitive neuroepithelium. Lab Invest. 1989, 60 (3): 390-398.PubMedGoogle Scholar
- Erlandsson A, Enarsson M, Forsberg-Nilsson K: Immature Neurons From CNS Stem Cells Proliferate in Response to Platelet-Derived Growth Factor. J Neurosci. 2001, 21 (10): 3483-3491.PubMedGoogle Scholar
- Ibarrola N, Rodriguez-Pena A: Hypothyroidism coordinately and transiently affects myelin protein gene expression in most rat brain regions during postnatal development. Brain Res. 1997, 752 (1-2): 285-293. 10.1016/S0006-8993(96)01480-1.View ArticlePubMedGoogle Scholar
- Smith J, Ladi E, Mayer-Proschel M, Noble M: Redox state is a central modulator of the balance between self-renewal and differentiation in a dividing glial precursor cell. Proc Natl Acad Sci U S A. 2000, 97 (18): 10032-10037. 10.1073/pnas.170209797.PubMed CentralView ArticlePubMedGoogle Scholar
- Lu QR, Yuk D, Alberta JA, Zhu Z, Pawlitzky I, Chan J, McMahon AP, Stiles CD, Rowitch DH: Sonic hedgehog--regulated oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system. Neuron. 2000, 25 (2): 317-329. 10.1016/S0896-6273(00)80897-1.View ArticlePubMedGoogle Scholar
- Takebayashi H, Yoshida S, Sugimori M, Kosako H, Kominami R, Nakafuku M, Nabeshima Y: Dynamic expression of basic helix-loop-helix Olig family members: implication of Olig2 in neuron and oligodendrocyte differentiation and identification of a new member, Olig3. Mechanisms of Development. 2000, 99 (1-2): 143-148. 10.1016/S0925-4773(00)00466-4.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.